Affordable Access

The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide.

Authors
Type
Published Article
Journal
Allergy
Publication Date
Volume
55
Issue
8
Pages
757–761
Identifiers
PMID: 10955702
Source
Medline
License
Unknown

Abstract

Topical administration of the NO-synthase inhibitor L-NAME at doses sufficient to decrease NO nasal production does not prevent the PAF-induced increase in NAR, indicating that NO generation in vivo is not involved in the nasal response to PAF.

Statistics

Seen <100 times